US firm patents key HIV gene
A biotechnology company set up to mine the human genome for targets for new drugs has said it had patented a gene considered key to HIV infection and working on therapies using the gene. Human Genome
A biotechnology company set up to mine the human genome for targets for new drugs has said it had patented a gene considered key to HIV infection and working on therapies using the gene. Human Genome